Google TrendSOCIAL SECURITY 2027 COLA ANNOUNCEMENT (500+) — When will 2027’s Social Security COLA be announced?
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Targeting plasminogen act" (30 stories)

Top Headline Story

Targeting plasminogen activator inhibitor 1 for cancer and longevity
Lead StoryNaturegeneral
Nov 28, 2025

Targeting plasminogen activator inhibitor 1 for cancer and longevity

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5lZUNYN0E4WEF3X0YtVHVxQ3pPVDB5M1Z1M3FKRWUyM1ZfNldYS19GaURxdFc3V3ZmcVh2alJ2YXhyNmtSLXRkWnJRdTQ3cU9pMllsSnRuWmpVc3dZRG9J?oc=5" target="_blank">Targeting plasminogen activator inhibitor 1 for cancer and longevity</a>  <font color="#6f6f6f">Nature</font>

Real-time search volume
500+22m ago

social security 2027 cola announcement

When will 2027’s Social Security COLA be announced?

200+32m ago

benfica vs vitória sc

Benfica tem 'roupa nova' para receber o V. Guimarães: o onze provável

200+32m ago

energy ceasefire

Trump announces partial ceasefire in Ukraine war as Zelenskyy says deal is ‘news to me’

200+32m ago

elliot anderson

James McAtee: How Oliver Glasner has transformed Nottingham Forest midfielder from forgotten man to his new Adam Wharton

Search Results for "Targeting plasminogen act"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Inflammatory macrophage-derived plasminogen activator inhibitor-1 exacerbates inflammation through efferocytosis inhibition
Naturegeneral

Inflammatory macrophage-derived plasminogen activator inhibitor-1 exacerbates inflammation through efferocytosis inhibition

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9pbTlvaUlneVA5cjRkVHJBSXJrMWc1NXBJZE5MRWdKWnFDZ0ZtejEyakJZakM3bmdWZTVyel85a25HWXVTR2p0Q3pVVnFidFRocl9lbF9uRi1Bcm5TSGpv?oc=5" target="_blank">Inflammatory macrophage-derived plasminogen activator inhibitor-1 exacerbates inflammation through efferocytosis inhibition</a>  <font color="#6f6f6f">Nature</font>

Drug Targeting of Plasminogen Activator Inhibitor-1 Inhibits Metabolic Dysfunction and Atherosclerosis in a Murine Model of Metabolic Syndrome
American Heart Association Journalsworld

Drug Targeting of Plasminogen Activator Inhibitor-1 Inhibits Metabolic Dysfunction and Atherosclerosis in a Murine Model of Metabolic Syndrome

<a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE1sVHg2aWwteF9QdHJBM3hYTGZJNzdETDVVbW9tUFR6UFhXczRzcUpCWlMxTGJydVVvVHNZV1g4RFFjTHk5M0JMUDh4NHRhRnoxNmlhWlF6SXViTnBMSldnSUJnVHdJOUZnM2c?oc=5" target="_blank">Drug Targeting of Plasminogen Activator Inhibitor-1 Inhibits Metabolic Dysfunction and Atherosclerosis in a Murine Model of Metabolic Syndrome</a>  <font color="#6f6f6f">American Heart Association Journals</font>

Fibrinogen-mimicking, multiarm nanovesicles for human thrombus-specific delivery of tissue plasminogen activator and targeted thrombolytic therapy
Science | AAASgeneral

Fibrinogen-mimicking, multiarm nanovesicles for human thrombus-specific delivery of tissue plasminogen activator and targeted thrombolytic therapy

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5PM0lwUnZ1SkJwY3FqZHpNU2FIcGdHcmRVcTVCU3QwN3lRRkc4Unp2amZPejhJaXI0d3JCNmFKZjNtckdvajZ2SHdYeDY5VFpHV3huSUZ0dHI2Z21xYlcw?oc=5" target="_blank">Fibrinogen-mimicking, multiarm nanovesicles for human thrombus-specific delivery of tissue plasminogen activator and targeted thrombolytic therapy</a>  <font color="#6f6f6f">Science | AAAS</font>

PAI-1 may be a promising therapeutic target for preventing age-related muscle and bone loss
News-Medicaltech

PAI-1 may be a promising therapeutic target for preventing age-related muscle and bone loss

<a href="https://news.google.com/rss/articles/CBMi1gFBVV95cUxQS2xuNFF5OFF3Nk11MXdYMGVTTWg3WTVBSmZDTjV1RG5XVjNCOFZlcEsxT3lOOTdydHRTWWZvUl8wQTlTQzd5YTNuV3JJazVVdDNfcmxBTUhfQmRVWFdETDdrSk1LSkdYNEJjdHFlcE9UNDhRazFuVVFZM0xMQ3V6VE9XVU5Xc2cwWGllckhYNjk2Z0UtSmdTZmVZMFV2MnRvVHFUUUdCenpya3pNdFpfeEpCbWZLcGtmWTVCTG93Vm9kajN4WDB2ZmNkaTNKUnBzZDdIa2xR?oc=5" target="_blank">PAI-1 may be a promising therapeutic target for preventing age-related muscle and bone loss</a>  <font color="#6f6f6f">News-Medical</font>

uTREAT therapy binds to aggressive gliomas in trial’s first patient
Rare Cancer Newsgeneral

uTREAT therapy binds to aggressive gliomas in trial’s first patient

<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxObS11YVAwWDUyVmVlWkJtcWdKd3ZDMi1qTDhwcmoxSUVuVDVQWHdaZXEwbkNuWXd2Yy1rUHFBRWpXdGJEYS1XZ0laSGFtNmRYZm0yVjZzQmw3MUNOMTMzc3gxS0gtaGFPNUxDOTVseE1NamxYenpNb1FUcDNkOFB5R1JvbV9qZXZfV2VaRWRSRUZIdGdSYmVz?oc=5" target="_blank">uTREAT therapy binds to aggressive gliomas in trial’s first patient</a>  <font color="#6f6f6f">Rare Cancer News</font>

Targeting the Urokinase-Type Plasminogen Activator Receptor (uPAR) in Human Diseases With a View to Non-invasive Imaging and Therapeutic Intervention
Frontiersgeneral

Targeting the Urokinase-Type Plasminogen Activator Receptor (uPAR) in Human Diseases With a View to Non-invasive Imaging and Therapeutic Intervention

<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxOTUxjWnB4dnZvd3BkQW1fem9SX285RVB0XzR0T3o4eFl6WndDVHJDVXc1bjVBOGhjT3VQdlpZNzVJRVd6WVJUY2E5SGVFbUpxVGlXOENzWThWYTBvUUdHYUVqTG4tUUJWcGR6eERZbE5UYnVCeWUwdUU4WHdzV0FCVDdRa1JNWVVDWkNyMDUzVVBpaWY5R3dqNzVrdmkxSHBlVXd4ZHVEWTBFd0E?oc=5" target="_blank">Targeting the Urokinase-Type Plasminogen Activator Receptor (uPAR) in Human Diseases With a View to Non-invasive Imaging and Therapeutic Intervention</a>  <font color="#6f6f6f">Frontiers</font>

Differentiating borderline HER2 -expressing and HER2 -positive cancers from other subtypes using serum urokinase plasminogen activator
Naturegeneral

Differentiating borderline HER2 -expressing and HER2 -positive cancers from other subtypes using serum urokinase plasminogen activator

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5EVy1PTU1BVEJ2dElyRUVCZ0ZfVzljVFYtS1c3T29sbVRQZlNuS0JobTZRLV9Va2ZQZWZSaHc2eVVkSWdEcmFQdFFTMmktTlVSLW4yRzFmWjJfTnljc200?oc=5" target="_blank">Differentiating borderline HER2 -expressing and HER2 -positive cancers from other subtypes using serum urokinase plasminogen activator</a>  <font color="#6f6f6f">Nature</font>

A catalytic switch and the conversion of streptokinase to a fibrin-targeted plasminogen activator
PNASgeneral

A catalytic switch and the conversion of streptokinase to a fibrin-targeted plasminogen activator

<a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTE1OaFhPM1g0MVh4RWJsSWs2ZHQ1S19LZWZwZXdncFB1bVYtY1VvdXVxZjVyV1IyM05wRmktRUpMeERKR1pkYVE2dFFsYWtWbHhpYmpzV0tuTmhUWmtS?oc=5" target="_blank">A catalytic switch and the conversion of streptokinase to a fibrin-targeted plasminogen activator</a>  <font color="#6f6f6f">PNAS</font>

Lipid nanoparticles and siRNA targeting plasminogen provide lasting inhibition of fibrinolysis in mouse and dog models of hemophilia A
Science | AAASgeneral

Lipid nanoparticles and siRNA targeting plasminogen provide lasting inhibition of fibrinolysis in mouse and dog models of hemophilia A

<a href="https://news.google.com/rss/articles/CBMiZ0FVX3lxTFB3QlhOTGdSTDV6YmxpeHFEMnBONDNFNGs3MHVjYWhSeHVhdWFaNHlxSzRrTWVVbU5BOWdVc19iZTFBX0JWNzE0UGcxZk92TXYweXpZVy1VcnlEbDFZUDA0R2RhVTR6ZGM?oc=5" target="_blank">Lipid nanoparticles and siRNA targeting plasminogen provide lasting inhibition of fibrinolysis in mouse and dog models of hemophilia A</a>  <font color="#6f6f6f">Science | AAAS</font>

A “ turn-off ” photoacoustic contrast for urokinase-type plasminogen activator activity
Naturegeneral

A “ turn-off ” photoacoustic contrast for urokinase-type plasminogen activator activity

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9nQzgtcHVPNVRvUVlwcGIwMmhNdHYtLWZoRXNZcnNXWmFuMVpTYmZYT1hYX1M2dTlrV3V4TDJ3a0l5R1ZiLVNsTmxUOFlCZTlNb0lDdkcwUjdRbVRDY3RF?oc=5" target="_blank">A “ turn-off ” photoacoustic contrast for urokinase-type plasminogen activator activity</a>  <font color="#6f6f6f">Nature</font>

Impacts of tissue-type plasminogen activator (tPA) on neuronal survival
Frontiersgeneral

Impacts of tissue-type plasminogen activator (tPA) on neuronal survival

<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxONUtuVkFoaGZuaC10UkE3NnFfMzYwQ3EtRmVyM3cyejJLMURwRkphb0luTGg1UVNHcEJ6Slh6UXYyXzdnQnk1ZlhMSlUzNVNKUGxldEFLRm1DUV9RUlAtZzNvOW9rRDlBQmZiSFdHZ1BtTkk3SU5ISHgyNzAzU3hlcGRNVWtCYVBfamgxZXo0XzdOTTFsZ0tvWjg5Y0pjZw?oc=5" target="_blank">Impacts of tissue-type plasminogen activator (tPA) on neuronal survival</a>  <font color="#6f6f6f">Frontiers</font>

Plasminogen Activator Inhibitor-1 Is a Marker and a Mediator of Senescence
American Heart Association Journalsgeneral

Plasminogen Activator Inhibitor-1 Is a Marker and a Mediator of Senescence

<a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE9YOUhwWUppOEZmbjN0RnJTS2twRThDZFhSRzRfYXAtWFR6SEdHRkFydkhPLUJMZDVVNU1PQ3FENDVJamZkb2FXUHo1cnZyUUtBc0x0cHhrQnVHN3hKQjlUeDRBZ0RGUVdyVUE?oc=5" target="_blank">Plasminogen Activator Inhibitor-1 Is a Marker and a Mediator of Senescence</a>  <font color="#6f6f6f">American Heart Association Journals</font>

Virus-derived serpin reduces immuno-coagulopathic damage in murine colitis by targeting the urokinase-type plasminogen activator receptor (uPAR) and complement
Natureworld

Virus-derived serpin reduces immuno-coagulopathic damage in murine colitis by targeting the urokinase-type plasminogen activator receptor (uPAR) and complement

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9wYl9ZajVta2xzVFNPbm1BSWxiZGxEZHlkZ1d1bWRlcElFUjJYMFl1eW5GZ1JxUGQwSFdUWlZDSGpMTmd3dmhTdmpoRFZiLWItNFF3eEZNWGFVeXFKNndz?oc=5" target="_blank">Virus-derived serpin reduces immuno-coagulopathic damage in murine colitis by targeting the urokinase-type plasminogen activator receptor (uPAR) and complement</a>  <font color="#6f6f6f">Nature</font>

Targeting uPAR with an antibody-drug conjugate suppresses tumor growth and reshapes the immune landscape in pancreatic cancer models
Science | AAASworld

Targeting uPAR with an antibody-drug conjugate suppresses tumor growth and reshapes the immune landscape in pancreatic cancer models

<a href="https://news.google.com/rss/articles/CBMiZEFVX3lxTFBoaWVmTERRMGJHYUtYY0RxejVNRVhIZHlFRXN3UGlUekdlYjZ1a2ExY3M2RnR2amFOYk4zdFFzNHktelptdzlUVXA3RnNGNUxMbVJCVGxwdkxSV2g1N2dXa2k3RUE?oc=5" target="_blank">Targeting uPAR with an antibody-drug conjugate suppresses tumor growth and reshapes the immune landscape in pancreatic cancer models</a>  <font color="#6f6f6f">Science | AAAS</font>

Thrombus-Targeting Polymeric Nanocarriers and Their Biomedical Applications in Thrombolytic Therapy
Frontiersgeneral

Thrombus-Targeting Polymeric Nanocarriers and Their Biomedical Applications in Thrombolytic Therapy

<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxOWnRxQlB5OHMzdGZQX0ZfamxLUmlfWmRHR29GeXJQWWZ3VnhUc2ZXTkk3Nzk3NXIzdlZyY1doc1RCbkp0eldqQU5SV2daM0J2elA0Zm9xZmhMWWZUNzZndmNjLTktWmlYNHVPT0Ryc2dQY29xb0ZyOHBRRl9JNVVxU21IN0I3MVRQSHZXU2dlUDA?oc=5" target="_blank">Thrombus-Targeting Polymeric Nanocarriers and Their Biomedical Applications in Thrombolytic Therapy</a>  <font color="#6f6f6f">Frontiers</font>

A Serpin With a Finger in Many PAIs: PAI-1's Central Function in Thromboinflammation and Cardiovascular Disease
Frontierstech

A Serpin With a Finger in Many PAIs: PAI-1's Central Function in Thromboinflammation and Cardiovascular Disease

<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxPR2Z1WS1RMEE3clZweEo0aUpNSlViQXU1UTJUTWM0M2NnSmJ4cnlNVVQ2OWtTNzYtU3lJS19rTW40SmxJWUdYWHNZNU1rUjg2NF9WSUpLUW1XeHc1WGlManhGQ1JWbkpfSVl1R1BrSWpKWG94NDhwOHhsc0ZPd2xKQXNIb1lXcnFBeE9IYVZOOEpCVmNaVFBWTmxWYVZoREdJ?oc=5" target="_blank">A Serpin With a Finger in Many PAIs: PAI-1's Central Function in Thromboinflammation and Cardiovascular Disease</a>  <font color="#6f6f6f">Frontiers</font>

Plasminogen activator inhibitor 1 is not a major causative factor for exacerbation in a mouse model of SARS-CoV-2 infection
Naturegeneral

Plasminogen activator inhibitor 1 is not a major causative factor for exacerbation in a mouse model of SARS-CoV-2 infection

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFB1eDJsUmdOcGdnTXhZSTdhSkNvQ3pwNGY5UWNnMHVRQ29zZGN0SHV1a3BmV1plRzlqLWY5WHhTc1lmMmpnY2REZnJnLWc0R1lKczBiT2FzbHlBUi1sdjNN?oc=5" target="_blank">Plasminogen activator inhibitor 1 is not a major causative factor for exacerbation in a mouse model of SARS-CoV-2 infection</a>  <font color="#6f6f6f">Nature</font>

Discovery and characterisation of an antibody that selectively modulates the inhibitory activity of plasminogen activator inhibitor-1 | Scientific Reports
Naturegeneral

Discovery and characterisation of an antibody that selectively modulates the inhibitory activity of plasminogen activator inhibitor-1 | Scientific Reports

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9mVS1qYjNjSXdMa0VzWkoxMmhlUzRVN0Fvbm0xdHp3dVo3ZVlQUkZiX1U4b09oVkZra3BQR0d6VEJZWm9TU1NrTk1YMEZXTkViNE5OWjRlaHkwV3FhMUI4?oc=5" target="_blank">Discovery and characterisation of an antibody that selectively modulates the inhibitory activity of plasminogen activator inhibitor-1 | Scientific Reports</a>  <font color="#6f6f6f">Nature</font>

Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence
Naturegeneral

Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence

<a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTE40d19TajFGQnpQeVpqNHFMLVBxMUdHRWJHMWlBMDBBdWM1LWdQamViVEVGdkJLejFDNlUzaHVVNHQtT1FOY0UxRlRYaTBmZ05i?oc=5" target="_blank">Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence</a>  <font color="#6f6f6f">Nature</font>

CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancer
Naturegeneral

CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancer

<a href="https://news.google.com/rss/articles/CBMiVEFVX3lxTE1DcVFFaW4xNkoxelZyNkJmMXZNOElXdFVYaHdVcFJQQWZsUXl6OWtONWMzTU8wRURQNDFleF9BR3RFN1JSMnkzNzVWcEphUFctYXdxUg?oc=5" target="_blank">CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancer</a>  <font color="#6f6f6f">Nature</font>

Targeting Fibrinolytic Inhibition for Venous Thromboembolism Treatment: Overview of an Emerging Therapeutic Approach
American Heart Association Journalsgeneral

Targeting Fibrinolytic Inhibition for Venous Thromboembolism Treatment: Overview of an Emerging Therapeutic Approach

<a href="https://news.google.com/rss/articles/CBMieEFVX3lxTE13eWx4dEp1RExQMEJUNmFuQS1MTHpTZHhRQWtQeU5jYTBGX3c0VUFRMDNBa2tTZFU0dVVzeFI1MXNRVUVJa3pNa3VBS3VQRUZDdXE3a25salAzQkFDNGhKdU1IZTFaaHNFaXBnNF90aV9acGhrUjZibA?oc=5" target="_blank">Targeting Fibrinolytic Inhibition for Venous Thromboembolism Treatment: Overview of an Emerging Therapeutic Approach</a>  <font color="#6f6f6f">American Heart Association Journals</font>

Astrocytes regulate the balance between plasminogen activation and plasmin clearance via cell-surface actin
Naturegeneral

Astrocytes regulate the balance between plasminogen activation and plasmin clearance via cell-surface actin

<a href="https://news.google.com/rss/articles/CBMiWEFVX3lxTFBpaVVJaUpLZDV5T2NCWWlwc29Idk5GamdObFVmTnVmaWtHM0ttQXdaVHJINFRDZFM5TVJzNkZoNHBHVHFfZ0NOczBlTTNIak5NRkhoZVZpYkw?oc=5" target="_blank">Astrocytes regulate the balance between plasminogen activation and plasmin clearance via cell-surface actin</a>  <font color="#6f6f6f">Nature</font>

Unbiased proteomics identifies plasminogen activator inhibitor-1 as a negative regulator of endothelial nitric oxide synthase
PNASworld

Unbiased proteomics identifies plasminogen activator inhibitor-1 as a negative regulator of endothelial nitric oxide synthase

<a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTE1QN0dpTG5WaklsWG05R0d5U0tmRXhyRUJhcEdoSy1xV295ZjJvNUpadFE4bmNxT2gyZURXWHhMM3RvWDRXYWFwcnJENDk4dDdscVNYdENnT2ZLcEk3?oc=5" target="_blank">Unbiased proteomics identifies plasminogen activator inhibitor-1 as a negative regulator of endothelial nitric oxide synthase</a>  <font color="#6f6f6f">PNAS</font>

Urokinase-type plasminogen activator receptor (uPAR) assessed by liquid biopsies and PET/CT for prognostication in head and neck cancer patients
Naturegeneral

Urokinase-type plasminogen activator receptor (uPAR) assessed by liquid biopsies and PET/CT for prognostication in head and neck cancer patients

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE92NzRwZWFHbm9BT2xnenJUOG1PdER6TVFiQW5uUTNEVjlrUUFveVdpUFVOSTNISC0xMHp0aHZXeHNHZElGcW1FSnpYODRGNXFER2VaMHlkOXJNZ0xxOV9J?oc=5" target="_blank">Urokinase-type plasminogen activator receptor (uPAR) assessed by liquid biopsies and PET/CT for prognostication in head and neck cancer patients</a>  <font color="#6f6f6f">Nature</font>

Exploitation of the fibrinolytic system by B-cell acute lymphoblastic leukemia and its therapeutic targeting
Naturegeneral

Exploitation of the fibrinolytic system by B-cell acute lymphoblastic leukemia and its therapeutic targeting

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9oYjFEdHV4MjA1MDRDRU5haWNPQ2dObTlQSVZJU19DbXlWYVZaNFcyWlQtemFPWW4wRUtTQ25LY1BRUkxOdEhOUTFqVFFTWjFSSlg1UUFfSzE3cWUyVTZF?oc=5" target="_blank">Exploitation of the fibrinolytic system by B-cell acute lymphoblastic leukemia and its therapeutic targeting</a>  <font color="#6f6f6f">Nature</font>

Deep mutational scanning of the plasminogen activator inhibitor-1 functional landscape
Natureworld

Deep mutational scanning of the plasminogen activator inhibitor-1 functional landscape

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1lTklvQUJqY0Q2RWdlbVM4QUhpdGZKeXgxVWE5Y016TUdieDZVcFRCdjI0dmg4aS13eWdkeWwtR1ZYVFl4cEZjWGNOZ2txU1lkYkstb3g0M2R3eDljXzJj?oc=5" target="_blank">Deep mutational scanning of the plasminogen activator inhibitor-1 functional landscape</a>  <font color="#6f6f6f">Nature</font>

PLAU contributes to the development of cholangiocarcinoma via activating NF-κB signaling pathway
Wiley Online Librarygeneral

PLAU contributes to the development of cholangiocarcinoma via activating NF-κB signaling pathway

<a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE9td3o5VkF3UlZ2NUdMY3hYMXFiakY1VW11ajI3d0pEQVo0djNUT1lBbV9hUS1iOTJSZFppVUhpeTFHUEU0ai1GYi1JYXhNYk9UYmtfa0k0RWJrRG5DcF9ZWmVvZGJUSE5BcHdz?oc=5" target="_blank">PLAU contributes to the development of cholangiocarcinoma via activating NF-κB signaling pathway</a>  <font color="#6f6f6f">Wiley Online Library</font>

PAI-1 and CHRNA1—A new molecular axis and therapeutic target in primary focal hyperhidrosis
ScienceDirect.comtech

PAI-1 and CHRNA1—A new molecular axis and therapeutic target in primary focal hyperhidrosis

<a href="https://news.google.com/rss/articles/CBMidkFVX3lxTE5aX2taeGhvNnNEWkoxNmlmYl9VYU9GWjhFcjg0bmNIaGhORlpiYWpUNE1CRkJQWVMzVW9yc25LQUFwbmowTVRJckpmQ19KVmY4aXY0UGlvdFh4dE8ta25hVnNNZFc2dW9JSFJNNGRZUnJpZnFnQkE?oc=5" target="_blank">PAI-1 and CHRNA1—A new molecular axis and therapeutic target in primary focal hyperhidrosis</a>  <font color="#6f6f6f">ScienceDirect.com</font>

Targeting proteolysis to halt arthritis
Naturegeneral

Targeting proteolysis to halt arthritis

<a href="https://news.google.com/rss/articles/CBMiWkFVX3lxTE5UM3hXX2c2aDlGMTRkVzZNMmFyVEs0UHQweXNvMms4RHgycVV1ZmJSZFFHY3N5UFpOSkE5aThURlZna1VtNFFIVUJfQy1FRkNRWFlCSzREWGhnZw?oc=5" target="_blank">Targeting proteolysis to halt arthritis</a>  <font color="#6f6f6f">Nature</font>

"Targeting plasminogen act" — Live Google News Trends & Headlines